• About
    • About CBDIA
    • Our Team
    • Advisory Board USA
    • Advisory Board LATAM
    • Committees
    • Bloggers
  • Join
    • Membership Benefits
    • Become A Member
    • Be A Regional Director
    • Connect With A Chapter
  • Events
  • Education Courses
  • Career Center
  • Webinars
  • Preferred Partners
  • Membership Directory
  • Contact
  • Membership
    • Login
    • Register
  • en English
    da Danishnl Dutchen Englishfr Frenchit Italianpt Portuguesees Spanish
  • Facebook
  • Instagram
CBD & Cannabinoid Industry AssociationCBD and Cannabinoid professionals committed to advancing the quality of the product and education of the industry.
  • Home
  • Wellness and Research
  • Legislation and Policy
    • FDA Regulation of Cannabis and Cannabis-Derived Products, Including Cannabidiol (CBD)
    • CBD Legal Status – Map
    • United States
    • Canada
    • Latin America
    • EU
  • CBD Business & Opinion
  • Advancement
  • News and Announcements
  • Certifications
    • Certified CBD Consultant
    • A Day with MacKay: The Cannabinoid Extraction Certification
    • Cannabinoid Sports Specialist (CSS)
    • Certified Flavonoid Specialist – CFS
    • Certified Cannabinoid Blending Formulator
    • Certified Minor PhytoCannabinoid Specialist™
    • Accredited TERPENE Specialist™️ Certification
    • Accredited CBD Compliance Consultant
    • Certified CBD Skincare Consultant
    • Certified CBD Pain Management Consultant
    • Certified Cannabinoid Senior Care Specialist
  • Membership
    • Register
    • Sign in
CBD & Cannabinoid Industry Association
  • Home
  • Wellness and Research
  • Legislation and Policy
    • FDA Regulation of Cannabis and Cannabis-Derived Products, Including Cannabidiol (CBD)
    • CBD Legal Status – Map
    • United States
    • Canada
    • Latin America
    • EU
  • CBD Business & Opinion
  • Advancement
  • News and Announcements
  • Certifications
    • Certified CBD Consultant
    • A Day with MacKay: The Cannabinoid Extraction Certification
    • Cannabinoid Sports Specialist (CSS)
    • Certified Flavonoid Specialist – CFS
    • Certified Cannabinoid Blending Formulator
    • Certified Minor PhytoCannabinoid Specialist™
    • Accredited TERPENE Specialist™️ Certification
    • Accredited CBD Compliance Consultant
    • Certified CBD Skincare Consultant
    • Certified CBD Pain Management Consultant
    • Certified Cannabinoid Senior Care Specialist
  • Membership
    • Register
    • Sign in
News and Announcements

U.S. to spend $3 million to find out if CBD can relieve pain

1 year ago
Add Comment
by Shared Content
83 Views
Shared Content
Written by Shared Content
The federal government still considers marijuana an illegal drug, but more than 30 states allow it use for a range of medical problems, some without good evidence.Jeff Chiu / AP file
By Associated Press

The U.S. government will spend $3 million to find out if marijuana can relieve pain, but none of the money will be used to study the part of the plant that gets people high.

Nine research grants announced Thursday are for work on CBD, the trendy ingredient showing up in cosmetics and foods, and hundreds of less familiar chemicals. THC research was excluded.

The federal government still considers marijuana an illegal drug, but more than 30 states allow it use for a range of medical problems, some without good evidence.

The science is strongest for chronic pain, the most common reason people give when they enroll in state-approved medical marijuana programs. But little is known about which parts of marijuana are helpful and whether the intoxicating effects of THC can be avoided.

“The science is lagging behind the public use and interest. We’re doing our best to catch up here,” said Dr. David Shurtleff, deputy director of the National Center for Complementary and Integrative Health, which is funding the projects.

THC has been investigated extensively, Shurtleff said, and its potential for addiction and abuse make it unsuitable for treating pain.

Other federal agencies have supported marijuana research, but much of the focus has been on potential harms. Shurtleff said the grants answer the call in a 2017 National Academies of Sciences, Engineering and Medicine report, which concluded a lack of marijuana research poses a public health risk.

Another driver is the nation’s opioid addiction crisis, with its roots in overuse of prescription painkillers. The crisis has sparked new scientific interest in marijuana’s pain-easing properties.

Dr. Judith Hellman, a grant recipient from University of California San Francisco, said scientists need to better understand pain and to find more ways to treat it. “It’s very exciting to have the opportunity to do that,” she said.

Hellman’s research involves the body’s ability to produce signaling molecules similar to marijuana’s ingredients. Her and Dr. Mark Schumacher’s work involves human immune cells in the lab, then tests on mice.

Human test subjects will be involved in only one of the grant projects. University of Utah researcher Deborah Yurgelun-Todd will scan the brains of human volunteers with lower back pain to see how CBD extract — mixed with chocolate pudding — affects pain-signaling pathways. Half the volunteers will get pudding without CBD as a control group.

Two more human studies may be funded in a second round of grant awards, NCCIH said.

In July, the National Institute on Drug Abuse said it would grow 2,000 kilograms (4,409 pounds) of marijuana this year at the University of Mississippi, which holds the sole federal contract for producing research cannabis. Those plants won’t be used in many of the new projects, which instead will use lab-made versions of the chemicals.

Researchers in Illinois hope to create a library of useful compounds found in cannabis plants.

“We make them from scratch and test them one by one,” said David Sarlah of the University of Illinois. Marijuana contains such tiny amounts of the interesting ingredients that it’s too costly and time consuming to isolate enough for research, Sarlah said.

Sarlah, an organic chemist, will make the chemicals. His colleague Aditi Das will run tests to see how they react with mouse immune cells.

“There are so many beneficial effects that patients report. We need to know the science behind it,” Das said.

Original Article: https://www.nbcnews.com/health/health-news/u-s-spend-3-million-find-out-if-cbd-can-n1056516

The Retail Market Will Make Up More Than 60% of CBD Sales in the U.S. by 2024
CBC – A Key Player in the Cannabinoid Family

You may also like

News and Announcements

The FDA Objects to the Sale and Marketing of Nasal...

News and Announcements

CBD: Shops for cannabis-derived products boom in France

News and Announcements

Industry groups, legal experts weigh implications of...

News and Announcements

Why did the hemp CBD market stagger through 2020?

News and Announcements

CBD Edibles Market Report: Only 1 in 4 CBD edibles...

News and Announcements

The impact of CBD in the wellness industry

About the author

Shared Content

Shared Content

View all posts

Leave a Comment X

  • CBDIA-Ad_Membership_300x250.png
  • Courses_Sidebar_Ad_400x350.png
  • MACEv365_Website_Promo_300x250-1.png
  • HT_digital_ad.jpg
  • CBDIA-_PreferredPartner_Ad_800x800-e1585761004927.png

Partner Publication

CBD Health & Wellness

Preferred Partners

  • court.png
  • mhp.png
  • download.png
  • PCCBD-Logo-trans.png

Advertisement

  • 125x125-01.png
  • 125x125-01.png

Partner Publication

Join Us

  • Facebook
  • Instagram

Talked About

  • This Opioid Producer Just Said Yes to Cannabis
  • The CBD Trend Shows No Signs of Slowing, But is it...
  • Medical Programs are Nosediving in Recreational...
  • Square Quietly Launches Program For CBD Cannabis...

Proud PR Partner

Marino

Email: CBDIA@marinopr.com

Website: marinopr.com

Follow on Feedly

follow us in feedly

We Transfer

Copyright ®2019 - CBD & Cannabinoid Industry Association - All rights reserved. Created and powered by Celeste Miranda & Associates.